Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 80 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

80 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
May 3, 2024 SABR P 50,000 $2.98 $149,000 587,665 Direct +9.30% Acquired -33.9% (price as of 2026-10-02)
Aug. 9, 2023 SABR P 2,903 $5.39 $15,647 499,429 Direct +0.58% Acquired -63.5% (price as of 2026-10-02)
Aug. 9, 2023 SABR P 22,097 $5.37 $118,661 521,526 Direct +4.42% Acquired -63.3% (price as of 2026-10-02)
Aug. 9, 2023 SABR P 25,000 $5.38 $134,500 546,526 Direct +4.79% Acquired -63.4% (price as of 2026-10-02)
Nov. 22, 2022 SABR P 75,000 $4.80 $360,000 184,170 Direct +68.70% Acquired -59.0% (price as of 2026-10-02)
Nov. 22, 2022 SABR P 25,000 $4.75 $118,750 209,170 Direct +13.57% Acquired -58.5% (price as of 2026-10-02)
Nov. 15, 2019 CVSA P 32,000 $33.73 $1,079,360 78,090 Direct +69.43% Acquired 272.0% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Aug. 26, 2020 CVSA Employee Stock Option (Right to Buy) Common Stock (26,775) $32.03 Aug. 26, 2030 26,775 Acquired
June 15, 2019 GRPN Restricted Stock Units Common Stock (31,226) · · 31,226 Disposed
April 25, 2019 GRPN Restricted Stock Units Common Stock (47,143) · · 47,143 Disposed
March 15, 2019 GRPN Restricted Stock Units Common Stock (56,603) · · 56,603 Disposed
March 15, 2019 GRPN Restricted Stock Units Common Stock (14,459) · · 14,459 Disposed
Feb. 12, 2019 GRPN Restricted Stock Units Common Stock (460,123) · · 460,123 Acquired
Feb. 12, 2019 GRPN Performance Share Units Common Stock (56,904) · · 56,904 Acquired
Feb. 12, 2019 GRPN Performance Share Units Common Stock (1,000,000) · · 1,000,000 Acquired
Jan. 25, 2019 GRPN Restricted Stock Units Common Stock (47,143) · · 47,143 Disposed
Dec. 15, 2018 GRPN Restricted Stock Units Common Stock (14,460) · · 14,460 Disposed
Oct. 25, 2018 GRPN Restricted Stock Units Common Stock (47,143) · · 47,143 Disposed
Sept. 15, 2018 GRPN Restricted Stock Units Common Stock (14,459) · · 14,459 Disposed
July 25, 2018 GRPN Restricted Stock Units Common Stock (47,143) · · 47,143 Disposed
June 15, 2018 GRPN Restricted Stock Units Common Stock (14,460) · · 14,460 Disposed
April 25, 2018 GRPN Restricted Stock Units Common Stock (55,000) · · 55,000 Disposed
Feb. 13, 2018 GRPN Restricted Stock Units Common Stock (283,018) · · 283,018 Acquired
Jan. 25, 2018 GRPN Restricted Stock Units Common Stock (55,000) · · 55,000 Disposed
Oct. 25, 2017 GRPN Restricted Stock Units Common Stock (55,000) · · 55,000 Disposed
July 25, 2017 GRPN Restricted Stock Units Common Stock (55,000) · · 55,000 Disposed
April 25, 2017 GRPN Restricted Stock Units Common Stock (287,581) · · 287,581 Disposed
Feb. 14, 2017 GRPN Restricted Stock Units Common Stock (182,741) · · 182,741 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 8 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Aug. 30, 2019 CVSA Common Stock · Direct
Aug. 30, 2019 CVSA Common Stock · Direct
Aug. 30, 2019 CVSA Employee Stock Option (Right to Buy)→ Common Stock (26,950) 26,950 Direct
May 9, 2016 GRPN Restricted Stock Units→ Class A Common Stock (696,153) 696,153 Direct
March 5, 2012 DAL Common Stock 33,375 Direct
March 5, 2012 DAL Employee Stock Option (Right to Buy [F2]→ Common Stock (8,900) 8,900 Direct
March 5, 2012 DAL Employee Stock Option (Right to Buy [F2]→ Common Stock (2,183) 2,183 Direct
March 5, 2012 DAL Employee Stock Option (Right to Buy [F2]→ Common Stock (40,800) 40,800 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CVSA

President and ChiefFinancial Officer
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2021 $519,231 · · · · · $19,292 $1,599,505
2020 $484,615 $400,000 · · $354,640 · $14,985 $4,211,548

GRPN

CFO
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2018 $500,000 · $2,898,475 · $240,000 · $10,410 $3,648,885
2017 $482,945 · $898,661 · $503,500 · $2,160 $1,887,266
2016 $277,913 $258,452 $3,494,618 · $289,931 · $8,938 $4,329,852

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.